Annual D&A
$2.03 M
+$895.20 K+79.11%
31 December 2023
Summary:
Cytosorbents annual depreciation & amortization is currently $2.03 million, with the most recent change of +$895.20 thousand (+79.11%) on 31 December 2023. During the last 3 years, it has risen by +$1.37 million (+206.72%). CTSO annual D&A is now at all-time high.CTSO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$428.80 K
-$17.70 K-3.96%
30 September 2024
Summary:
Cytosorbents quarterly depreciation & amortization is currently $428.80 thousand, with the most recent change of -$17.70 thousand (-3.96%) on 30 September 2024. Over the past year, it has dropped by -$33.80 thousand (-7.31%). CTSO quarterly D&A is now -45.91% below its all-time high of $792.70 thousand, reached on 31 December 2023.CTSO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.11 M
-$33.80 K-1.58%
30 September 2024
Summary:
Cytosorbents TTM depreciation & amortization is currently $2.11 million, with the most recent change of -$33.80 thousand (-1.58%) on 30 September 2024. Over the past year, it has increased by +$598.40 thousand (+39.56%). CTSO TTM D&A is now -2.07% below its all-time high of $2.16 million, reached on 31 March 2024.CTSO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +79.1% | -7.3% | +39.6% |
3 y3 years | +206.7% | +80.8% | +209.1% |
5 y5 years | +418.9% | +209.2% | +285.3% |
CTSO Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +206.7% | -45.9% | +80.8% | -2.1% | +209.1% |
5 y | 5 years | at high | +418.9% | -45.9% | +246.4% | -2.1% | +285.3% |
alltime | all time | at high | >+9999.0% | -45.9% | +796.1% | -2.1% | >+9999.0% |
Cytosorbents Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $428.80 K(-4.0%) | $2.11 M(-1.6%) |
June 2024 | - | $446.50 K(+0.7%) | $2.15 M(-0.5%) |
Mar 2024 | - | $443.20 K(-44.1%) | $2.16 M(+6.4%) |
Dec 2023 | $2.03 M(+79.1%) | $792.70 K(+71.4%) | $2.03 M(+34.0%) |
Sept 2023 | - | $462.60 K(+1.1%) | $1.51 M(+13.9%) |
June 2023 | - | $457.40 K(+45.6%) | $1.33 M(+14.1%) |
Mar 2023 | - | $314.10 K(+12.7%) | $1.16 M(+2.8%) |
Dec 2022 | $1.13 M(+0.2%) | $278.70 K(+0.4%) | $1.13 M(-22.8%) |
Sept 2022 | - | $277.60 K(-5.4%) | $1.47 M(+2.8%) |
June 2022 | - | $293.30 K(+4.0%) | $1.42 M(+13.5%) |
Mar 2022 | - | $282.10 K(-53.9%) | $1.26 M(+11.1%) |
Dec 2021 | $1.13 M(+70.9%) | $612.40 K(+158.3%) | $1.13 M(+65.4%) |
Sept 2021 | - | $237.10 K(+91.5%) | $683.00 K(+13.6%) |
June 2021 | - | $123.80 K(-20.8%) | $601.00 K(-5.5%) |
Mar 2021 | - | $156.30 K(-5.7%) | $635.70 K(-3.8%) |
Dec 2020 | $660.80 K(+13.6%) | $165.80 K(+6.9%) | $660.80 K(-0.2%) |
Sept 2020 | - | $155.10 K(-2.1%) | $662.40 K(+2.5%) |
June 2020 | - | $158.50 K(-12.6%) | $646.00 K(+3.4%) |
Mar 2020 | - | $181.40 K(+8.4%) | $624.70 K(+7.4%) |
Dec 2019 | $581.50 K(+48.9%) | $167.40 K(+20.7%) | $581.50 K(+6.1%) |
Sept 2019 | - | $138.70 K(+1.1%) | $547.90 K(-0.1%) |
June 2019 | - | $137.20 K(-0.7%) | $548.50 K(+16.2%) |
Mar 2019 | - | $138.20 K(+3.3%) | $472.20 K(+20.9%) |
Dec 2018 | $390.60 K(+78.9%) | $133.80 K(-3.9%) | $390.60 K(+24.6%) |
Sept 2018 | - | $139.30 K(+128.7%) | $313.40 K(+35.0%) |
June 2018 | - | $60.90 K(+7.6%) | $232.20 K(+9.7%) |
Mar 2018 | - | $56.60 K(0.0%) | $211.60 K(-3.1%) |
Dec 2017 | $218.30 K(+35.1%) | $56.60 K(-2.6%) | $218.30 K(+2.1%) |
Sept 2017 | - | $58.10 K(+44.2%) | $213.90 K(+9.2%) |
June 2017 | - | $40.30 K(-36.3%) | $195.80 K(+1.7%) |
Mar 2017 | - | $63.30 K(+21.3%) | $192.50 K(+19.1%) |
Dec 2016 | $161.60 K(+43.0%) | $52.20 K(+30.5%) | $161.60 K(+12.3%) |
Sept 2016 | - | $40.00 K(+8.1%) | $143.90 K(+4.4%) |
June 2016 | - | $37.00 K(+14.2%) | $137.90 K(+11.0%) |
Mar 2016 | - | $32.40 K(-6.1%) | $124.20 K(+10.0%) |
Dec 2015 | $113.00 K | $34.50 K(+1.5%) | $112.90 K(+53.6%) |
Sept 2015 | - | $34.00 K(+45.9%) | $73.50 K(+14.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2015 | - | $23.30 K(+10.4%) | $64.40 K(-4.0%) |
Mar 2015 | - | $21.10 K(-530.6%) | $67.10 K(+2.3%) |
Dec 2014 | $65.50 K(+1.7%) | -$4900.00(-119.7%) | $65.60 K(-24.9%) |
Sept 2014 | - | $24.90 K(-4.2%) | $87.30 K(+11.4%) |
June 2014 | - | $26.00 K(+32.7%) | $78.40 K(+12.3%) |
Mar 2014 | - | $19.60 K(+16.7%) | $69.80 K(+8.6%) |
Dec 2013 | $64.40 K(+17.9%) | $16.80 K(+5.0%) | $64.30 K(-8.1%) |
Sept 2013 | - | $16.00 K(-8.0%) | $70.00 K(+8.2%) |
June 2013 | - | $17.40 K(+23.4%) | $64.70 K(+11.6%) |
Mar 2013 | - | $14.10 K(-37.3%) | $58.00 K(+6.2%) |
Dec 2012 | $54.60 K(+39.6%) | $22.50 K(+110.3%) | $54.60 K(+110.0%) |
Sept 2012 | - | $10.70 K(0.0%) | $26.00 K(-15.3%) |
June 2012 | - | $10.70 K(0.0%) | $30.70 K(-27.9%) |
Mar 2012 | - | $10.70 K(-275.4%) | $42.60 K(+9.0%) |
Dec 2011 | $39.10 K(+119.7%) | -$6100.00(-139.6%) | $39.10 K(-21.3%) |
Sept 2011 | - | $15.40 K(-31.9%) | $49.70 K(+28.4%) |
June 2011 | - | $22.60 K(+213.9%) | $38.70 K(+88.8%) |
Mar 2011 | - | $7200.00(+60.0%) | $20.50 K(+15.8%) |
Dec 2010 | $17.80 K(-65.6%) | $4500.00(+2.3%) | $17.70 K(-33.5%) |
Sept 2010 | - | $4400.00(0.0%) | $26.60 K(-24.4%) |
June 2010 | - | $4400.00(0.0%) | $35.20 K(-19.1%) |
Mar 2010 | - | $4400.00(-67.2%) | $43.50 K(-15.9%) |
Dec 2009 | $51.70 K(-50.1%) | $13.40 K(+3.1%) | $51.70 K(-19.5%) |
Sept 2009 | - | $13.00 K(+2.4%) | $64.20 K(-16.7%) |
June 2009 | - | $12.70 K(+0.8%) | $77.10 K(-14.6%) |
Mar 2009 | - | $12.60 K(-51.4%) | $90.30 K(-12.8%) |
Dec 2008 | $103.70 K(-45.5%) | $25.90 K(0.0%) | $103.60 K(-15.9%) |
Sept 2008 | - | $25.90 K(0.0%) | $123.20 K(-15.4%) |
June 2008 | - | $25.90 K(0.0%) | $145.70 K(-13.4%) |
Mar 2008 | - | $25.90 K(-43.1%) | $168.30 K(-11.6%) |
Dec 2007 | $190.40 K(-84.8%) | $45.50 K(-6.0%) | $190.40 K(+31.4%) |
Sept 2007 | - | $48.40 K(-0.2%) | $144.90 K(+50.2%) |
June 2007 | - | $48.50 K(+1.0%) | $96.50 K(+101.0%) |
Mar 2007 | - | $48.00 K(+3592.3%) | $48.00 K(+1233.3%) |
Dec 2006 | $1.26 M | - | - |
Feb 2006 | - | $1300.00(-102.1%) | $3600.00(+56.5%) |
Nov 2005 | - | -$61.60 K(-196.4%) | $2300.00(-96.4%) |
Aug 2005 | - | $63.90 K | $63.90 K |
FAQ
- What is Cytosorbents annual depreciation & amortization?
- What is the all time high annual D&A for Cytosorbents?
- What is Cytosorbents annual D&A year-on-year change?
- What is Cytosorbents quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cytosorbents?
- What is Cytosorbents quarterly D&A year-on-year change?
- What is Cytosorbents TTM depreciation & amortization?
- What is the all time high TTM D&A for Cytosorbents?
- What is Cytosorbents TTM D&A year-on-year change?
What is Cytosorbents annual depreciation & amortization?
The current annual D&A of CTSO is $2.03 M
What is the all time high annual D&A for Cytosorbents?
Cytosorbents all-time high annual depreciation & amortization is $2.03 M
What is Cytosorbents annual D&A year-on-year change?
Over the past year, CTSO annual depreciation & amortization has changed by +$895.20 K (+79.11%)
What is Cytosorbents quarterly depreciation & amortization?
The current quarterly D&A of CTSO is $428.80 K
What is the all time high quarterly D&A for Cytosorbents?
Cytosorbents all-time high quarterly depreciation & amortization is $792.70 K
What is Cytosorbents quarterly D&A year-on-year change?
Over the past year, CTSO quarterly depreciation & amortization has changed by -$33.80 K (-7.31%)
What is Cytosorbents TTM depreciation & amortization?
The current TTM D&A of CTSO is $2.11 M
What is the all time high TTM D&A for Cytosorbents?
Cytosorbents all-time high TTM depreciation & amortization is $2.16 M
What is Cytosorbents TTM D&A year-on-year change?
Over the past year, CTSO TTM depreciation & amortization has changed by +$598.40 K (+39.56%)